Sectoral Asset Management as of Dec. 31, 2017
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 67 positions in its portfolio as reported in the December 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amicus Therapeutics (FOLD) | 5.1 | $41M | 2.9M | 14.39 | |
Apellis Pharmaceuticals (APLS) | 4.8 | $38M | 1.8M | 21.70 | |
ACADIA Pharmaceuticals (ACAD) | 4.3 | $34M | 1.1M | 30.11 | |
Pfizer (PFE) | 3.9 | $32M | 870k | 36.22 | |
Novartis (NVS) | 3.9 | $32M | 376k | 83.96 | |
Acceleron Pharma | 3.8 | $30M | 712k | 42.44 | |
Johnson & Johnson (JNJ) | 3.7 | $30M | 214k | 139.72 | |
La Jolla Pharmaceuticl Com Par | 3.4 | $28M | 854k | 32.18 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 3.3 | $26M | 1.4M | 18.46 | |
Portola Pharmaceuticals | 3.3 | $26M | 536k | 48.68 | |
Celgene Corporation | 3.0 | $24M | 232k | 104.36 | |
Teladoc (TDOC) | 3.0 | $24M | 682k | 34.85 | |
BioMarin Pharmaceutical (BMRN) | 2.9 | $23M | 259k | 89.17 | |
Aerie Pharmaceuticals | 2.8 | $22M | 369k | 59.75 | |
Abbott Laboratories (ABT) | 2.7 | $22M | 383k | 57.07 | |
K2m Group Holdings | 2.6 | $21M | 1.2M | 18.00 | |
UnitedHealth (UNH) | 2.3 | $18M | 83k | 220.46 | |
Edwards Lifesciences (EW) | 2.2 | $18M | 158k | 112.71 | |
Global Blood Therapeutics In | 2.2 | $17M | 442k | 39.35 | |
Abiomed | 2.0 | $16M | 85k | 187.40 | |
Regeneron Pharmaceuticals (REGN) | 1.9 | $15M | 39k | 375.95 | |
Medtronic (MDT) | 1.8 | $15M | 182k | 80.75 | |
Eli Lilly & Co. (LLY) | 1.7 | $14M | 164k | 84.46 | |
CIGNA Corporation | 1.7 | $14M | 68k | 203.09 | |
Sarepta Therapeutics (SRPT) | 1.7 | $13M | 239k | 55.64 | |
Loxo Oncology | 1.6 | $13M | 152k | 84.18 | |
Clovis Oncology | 1.6 | $12M | 183k | 68.00 | |
Neurocrine Biosciences (NBIX) | 1.4 | $11M | 142k | 77.59 | |
Irhythm Technologies (IRTC) | 1.4 | $11M | 195k | 56.05 | |
EXACT Sciences Corporation (EXAS) | 1.3 | $10M | 193k | 52.54 | |
Viewray (VRAYQ) | 1.1 | $8.8M | 947k | 9.26 | |
Abbvie (ABBV) | 1.0 | $8.2M | 85k | 96.71 | |
Nektar Therapeutics (NKTR) | 0.9 | $7.0M | 118k | 59.72 | |
Momenta Pharmaceuticals | 0.9 | $7.0M | 500k | 13.95 | |
Prothena (PRTA) | 0.9 | $6.9M | 184k | 37.49 | |
Wright Medical Group Nv | 0.8 | $6.8M | 308k | 22.20 | |
Insulet Corporation (PODD) | 0.8 | $6.5M | 95k | 69.00 | |
Ptc Therapeutics I (PTCT) | 0.8 | $6.2M | 373k | 16.68 | |
Albireo Pharma | 0.8 | $6.2M | 243k | 25.60 | |
Masimo Corporation (MASI) | 0.8 | $6.2M | 73k | 84.79 | |
Merck & Co (MRK) | 0.8 | $6.1M | 109k | 56.27 | |
Evolent Health (EVH) | 0.8 | $6.1M | 492k | 12.30 | |
Integra LifeSciences Holdings (IART) | 0.7 | $5.9M | 123k | 47.86 | |
Hill-Rom Holdings | 0.7 | $5.9M | 70k | 84.29 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.7 | $5.5M | 37k | 149.86 | |
Spark Therapeutics | 0.5 | $4.3M | 83k | 51.42 | |
Acadia Healthcare (ACHC) | 0.5 | $4.1M | 127k | 32.63 | |
Molina Healthcare (MOH) | 0.5 | $4.0M | 52k | 76.67 | |
Incyte Corporation (INCY) | 0.5 | $3.7M | 39k | 94.70 | |
Madrigal Pharmaceuticals (MDGL) | 0.4 | $3.4M | 37k | 91.78 | |
Tesaro | 0.4 | $3.0M | 37k | 82.87 | |
Insmed (INSM) | 0.3 | $2.8M | 90k | 31.18 | |
Sage Therapeutics (SAGE) | 0.3 | $2.8M | 17k | 164.71 | |
Agios Pharmaceuticals (AGIO) | 0.3 | $2.7M | 48k | 57.18 | |
Accuray Incorporated (ARAY) | 0.3 | $2.6M | 595k | 4.30 | |
Savara (SVRA) | 0.3 | $2.4M | 160k | 14.84 | |
Obseva Sa | 0.3 | $2.1M | 211k | 9.76 | |
Intec Pharma | 0.2 | $1.8M | 355k | 5.15 | |
Proteostasis Therapeutics In | 0.2 | $1.7M | 300k | 5.83 | |
Spring Bk Pharmaceuticals In | 0.2 | $1.7M | 123k | 13.44 | |
Puma Biotechnology (PBYI) | 0.2 | $1.5M | 15k | 98.87 | |
Esperion Therapeutics (ESPR) | 0.2 | $1.5M | 23k | 65.83 | |
Dbv Technologies S A (DBVT) | 0.2 | $1.5M | 60k | 24.59 | |
Clementia | 0.2 | $1.4M | 75k | 18.97 | |
Zai Lab (ZLAB) | 0.1 | $1.1M | 50k | 21.24 | |
Dr. Reddy's Laboratories (RDY) | 0.1 | $958k | 26k | 37.57 | |
Sierra Oncology | 0.1 | $752k | 202k | 3.73 |